Q

Qualigen Therapeutics
D

QLGN

4.16000
USD
-0.20
(-4.59%)
مغلق
حجم التداول
5,458
الربح لكل سهم
-6
العائد الربحي
-
P/E
1
حجم السوق
8,457,580
أصول ذات صلة الأخبار المقالات

العنوان: Qualigen Therapeutics Inc

القطاع: Healthcare
الصناعة: Biotechnology
Qualigen Therapeutics Inc is an early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's program, QN-302, is an investigational small-molecule G-quadruplexes (G4)-selective transcription inhibitor with binding affinity to G4s prevalent in cancer cells.